發(fā)布時間：2017-03-01 14:51

【 Abstract 】 Objective: Small cell carcinoma of the cervix (SCCC) the clinical features, diagnosis and treatment process analysis and prognosis.Methods: 12 cases of SCCC patients clinical data were reviewed, analyzed the clinical characteristics, diagnosis, treatment and prognosis.Result :49 patients are performance have different degree of vagina drainage anomaly, bleeding, cervical local tumor of all the cauliflower shape wait for a phenomenon. FIGO staging: including stage I 8 cases of stage II, 30 cases, 6 cases of stage III and IV b cases in 5 patients. The radiation 23 cases, surgery and postoperative chemotherapy (26 cases), pelvic lymph node positive patients in 15 cases, vascular tumor patients with pin 11 cases. According to the different condition after radiotherapy, chemotherapy, surgical method combined treatment in patients with stage I no death, phase II of the patients in 4 cases of death, phase III 2 cases died, IV b 4 cases were died.
Conclusion: For SCCC, lymphatic invasion and vascular tumor bolt, staging is the main factors of prognosis. Surgery and release, chemotherapy combined treatment for early treatment has good curative effect. Implement chemotherapy can to control the distant metastasis has good effect, and postoperative radiotherapy can further prevent local pelvic recurrence phenomenon, the chemoradiation is toxic, but can tolerate, overall survival rate is not high, with poor prognosis.
Keywords: SCCC; diagnosis; Comprehensive treatment; prognosis.

做為臨床上較為特殊的嚴重的惡性腫瘤，宮頸小細胞癌(small cell carcinoma of the cervix，SCCC)在宮頸浸潤癌中的比例約占0.8％至2％。它的臨床表現同臨床常見宮頸浸潤癌極為相似，但是其生物學的行為卻與宮頸浸潤癌有很大差異。淋巴侵犯以及脈管瘤栓是危及生命的主要因素。手術與放、化療聯(lián)合治療對早期治療有著較好的療效。由于SCCC的惡性程度相對較高且其生長迅速快，而且還具有在早期就會發(fā)生轉移等惡性的生物學特點，并且其預后差，，臨床資料表明在其經過初次治療后其無瘤的間期一般都不到2年，通常會在6-12個月再次復發(fā)。5年的生存率更是較低。在目前的臨床治療上通常會與治療小細胞肺癌以及傳統(tǒng)的宮頸癌治療方法相同。但是對SCCC的治療的效果以及其預后并不理想。本文就49例SCCC患者資料進行臨床回顧，探討分析其臨床特點，診斷，治療以及預后。具體如下：

1、臨床資料

1.1 一般資料
1.2 治療方法
2、結果
3、討論

參考文獻



本文編號：246681